Equipment Maintenance for Two Illumina NextSeq 2000 Sequencers

This is a combined for commercial products or commercial services prepared in accordance with part 12. This announcement constitutes the only solicitation. Offers are being requested, and a separate written solicitation will not be issued. Solicitation number 75N98026Q00043-RFQ is issued as a request for quotation (RFQ) for Equipment Maintenance Contract for two (2) Illumina NextSeq 2000. This acquisition is not set-aside for small business concerns. This solicitation incorporates provisions and clauses by reference. The full text of provisions and clauses may be accessed electronically at https://www.acquisition.gov/far-overhaul/far-part-deviation-guide/far-overhaul-part-52. The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL AND OPEN COMPETITION (INCLUDING BRAND-NAME). The (OMAS), (OA), on behalf of the National Cancer Institute (NCI), intends to negotiate and award a firm-fixed-price purchase order, without providing for full and open competition (including brand-name), to Illumina, Inc., 5200 Illumina Way San Diego, CA 92122-4616 USA for equipment maintenance services for the Illumina NextSeq 2000. This acquisition is conducted as non-competitive for a commercial product or commercial service and is conducted pursuant to FAR 12.201-1, Simplified Procedures in accordance with 41 U.S.C. 1901. Illumina, Inc. (Illumina) currently provides routine maintenance for the Illumina NextSeq 2000. Illumina is the only authorized company that can provide service to the manufacturers Specification while providing OEM parts for it. Illumina does not offer 3rd party resellers to provide maintenance for their equipment. (ii) List of line-item number(s) and items, quantities, and units of measure (including option(s), if applicable) for this requirement (as applicable): CLIN 1 - Illumina NextSeq 2000 Silver Support Plan, Serial # VH01088, Catalog # 20040667;

Period of Performance: 04/01/2026-03/31/2027. CLIN 2 - Illumina NextSeq 2000 Silver Support Plan, Serial # VH00254, Catalog # 20040667,

Period of Performance: 04/01/2026-03/31/2027.

• (iii) For further descriptions and details about the maintenance services to be acquired, see Attachment 1 – Statement of Work (SOW).
• (iv) The Government anticipates award of a firm fixed-price purchase order for this acquisition, and the anticipated

period of performance is 04/01/2026-03/31/2027. Onsite services shall be performed at the following location: Genetics Branch, CCR, NCI 37 Convent Drive Building 37, Room 6016 Bethesda MD 20892 (v) The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998), applies to this acquisition. This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the

Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at this address: https://www.acquisition.gov/far-overhaul. (End of provision) a) The following FAR provision is required by FAR 12.205(a), and incorporated by reference: FAR 52.212-1,